From wieland@btm2d1.mat.uni-bayreuth.de  Wed Jul 10 06:13:06 1996
Received: from btm2d1.mat.uni-bayreuth.de  for wieland@btm2d1.mat.uni-bayreuth.de
	by www.ccl.net (8.7.5/950822.1) id FAA00929; Wed, 10 Jul 1996 05:25:05 -0400 (EDT)
From: <wieland@btm2d1.mat.uni-bayreuth.de>
Received: by btm2d1.mat.uni-bayreuth.de (IBM OS/2 SENDMAIL VERSION 1.3.14/2.12um) id AA0800; Wed, 10 Jul 96 11:24:55 +0200
Message-Id: <9607100924.AA0800@btm2d1.mat.uni-bayreuth.de>
Mime-Version: 1.0
Date: Wed, 10 Jul 96 10:04:43 +0200
To: MOL-DIVERSITY@LISTSERV.ARIZONA.EDU, chemistry@www.ccl.net
Subject: Summary: Toplogical indices and active sites
X-Mailer: Ultimedia Mail/2 Lite, IBM T. J. Watson Research Center
Content-Id: <246_96_1_837007483>
Content-Type: text/plain; charset="US-ASCII"
Content-Transfer-Encoding: 7bit


Dear netters,

last week I posted a question about the connections between topological indices,
similarity, screening and drug design. There were 9 summarizable replies most of 
which were rather lengthy. In order to avoid filling your mail boxes with too much
trash, this is just an announcement about the availability of the summary.
You can get it from:

   http://www.mathe2.uni-bayreuth.de/thomas/summary.html

or I send it to you as e-mail on your request.
My deep thanks go to all who responded. I think we should keep the track on this
issue.

Best regards,

Thomas Wieland